Fineline Cube

Follow:
14735 Articles
Policy / Regulatory

China’s Plan to Strengthen Medical and Healthcare Service System Unveiled

CompanyDeals

Alphax Bio Raises Millions for Spatial Proteomics and Tumor Immune Microenvironment Research

CompanyDrug

Luye Pharma’s Lurbinectedin Gains Priority Review Status for SCLC Treatment

CompanyDrug

Guangdong Zhongsheng’s RAY1216 Receives Conditional Approval for COVID-19 Treatment

CompanyDrug

Hengrui Pharmaceuticals’ HRS-5965 Receives NMPA Approval for Clinical Study in Hemolytic Anemia

CompanyDrug

Sunshine Guojian Completes Patient Enrollment for SSGJ-611 Phase II Study in Atopic Dermatitis

CompanyDrug

Henlius Biotech’s Serplulimab Accepted for EMA Review for ES-SCLC Treatment

CompanyDeals

Sino Biopharmaceutical’s F-star Therapeutics Signs Second Licensing Deal with Takeda

CompanyDrug

AstraZeneca’s Calquence Receives Conditional Approval in China for MCL

CompanyDeals

Biohaven Acquires Global Rights for Dual TYK2/JAK1 Inhibitor BHV-8000 from Highlightll

CompanyDrug

Hinova Pharmaceuticals’ HC-1119 NDA Accepted for Review by NMPA

CompanyDrug

Boehringer Ingelheim Initiates Phase III FIBRONEER Studies for PDE4B Inhibitor BI 1015550